Ad
related to: prtk stock
Search results
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) is definitely on the radar of institutional investors...
Simply Wall St. via Yahoo Finance· 8 months agoKey Insights Significantly high institutional ownership implies Paratek Pharmaceuticals' stock price...
Paratek Pharmaceuticals (PRTK) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoParatek (PRTK) delivered earnings and revenue surprises of 5.71% and 3.45%, respectively, for the...
Could The Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Ownership Structure Tell Us Something Useful?
Simply Wall St. via Yahoo Finance· 2 years agoThe big shareholder groups in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) have power over the...
Paratek Pharmaceuticals (NASDAQ:PRTK) investors are sitting on a loss of 83% if they invested five...
Simply Wall St. via Yahoo Finance· 1 year agoLong term investing is the way to go, but that doesn't mean you should hold every stock forever. It...
Individual investors account for 39% of Paratek Pharmaceuticals, Inc.'s (NASDAQ:PRTK) ownership,...
Simply Wall St. via Yahoo Finance· 1 year agoIf you want to know who really controls Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK), then you'll...
Even after rising 25% this past week, Paratek Pharmaceuticals (NASDAQ:PRTK) shareholders are still...
Simply Wall St. via Yahoo Finance· 2 years agoIt's nice to see the Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) share price up 25% in a week. But...
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Is Expected To Breakeven In The Near Future
Simply Wall St. via Yahoo Finance· 2 years agoParatek Pharmaceuticals, Inc. (NASDAQ:PRTK) is possibly approaching a major achievement in its...
News Flash: Analysts Just Made A Captivating Upgrade To Their Paratek Pharmaceuticals, Inc....
Simply Wall St. via Yahoo Finance· 10 months agoParatek Pharmaceuticals, Inc. (NASDAQ:PRTK) shareholders will have a reason to smile today, with the...
There's No Escaping Paratek Pharmaceuticals, Inc.'s (NASDAQ:PRTK) Muted Revenues Despite A 77% Share...
Simply Wall St. via Yahoo Finance· 1 year agoParatek Pharmaceuticals, Inc. (NASDAQ:PRTK) shareholders would be excited to see that the share...
7 Growth Stocks That Are Too Cheap to Ignore Right Now
InvestorPlace via Yahoo Finance· 1 year agoAlthough the equities sector recovered reasonably well from 2022’s harsh glare, rising headwinds...
